5 Things in ePharmacy You Need to Know This Friday 10/03/23
5 Things in ePharmacy You Need to Know This Friday 10/03/23
New Partnership [🇺🇸]
Walgreens Partners with DoorDash & Uber for Free Same Day Rx Delivery of HIV Meds in the US
Walgreens has partnered with DoorDash and Uber to offer free same-day delivery of HIV meds. Eligible patients within 15 miles of participating Walgreens pharmacies across the US can access the service, which supports the country’s HIV/AIDS strategy to reduce new HIV infections by 75% by 2025 and 90% by 2030. According to Uber’s Head of Global Social Impact, Julia Paige, this collaboration seeks to lower access barriers so that individuals in need can have their meds delivered straight to their door at no cost.
Read More: Walgreens
New Research [🇪🇪]
Estonian ePharmacies Continue to Maintain Popularity in the Post-pandemic Scenery
Estonian ePharmacies continue to retain the market share gained during the pandemic, with their share of total pharmacy sales remaining high even after the pandemic has ended. Statistics from the State Agency of Medicines (SAM) show that the share of online sales was 2.2% in the Q4 of 2022. ePharmacies offer Rx meds, OTCs, OTC veterinary medicines and other pharmacy products.
Read More: News ERR [article in Estonian]. Google Translate in English here.
Financial Results [🇬🇧]
UK-based Lloydspharmacy Cuts Losses Due to Impressive Online Growth in 2021/22
Lloydspharmacy has announced impressive growth in its online business, which helped it reduce losses, despite a 3.4% drop in overall turnover to £1.7Β. The company's website saw a 28% growth in 2021/22, Lloydspharmacy Online Doctor a 3% growth, and LloydsDirect a 55% growth, according to the report. Although the COVID-19 pandemic and the challenging government funding model for community pharmacy in the UK put great strain on the sector, the company's online growth was a significant positive, helping improve its financial position.
Read More: Chemist and Druggist
eCommerce [🇧🇷]
Ultrafarma Launches Brazil's First Pet ePharmacy with Low Prices
Brazil's ePharmacy, Ultrafarma, has launched the country's first pet ePharmacy, with affordable prices. The new service was developed to meet the needs of pet owners who often end up paying high prices for medication. With the slogan "Ultrafarma Pet, specialist in the health and well-being of your pet," the firm guarantees product excellence, low prices, and quality service. The company's Commercial Director said the launch will provide affordable medicines to a new segment that is increasingly becoming part of Brazilian families' lives.
Read More: Grandes Nomes da Propaganda [article in German]. Google Translate in English here.
Editor’s Choice [🇩🇪]
Shop Apotheke’s CEO Stefan Feltens to Step Down for Personal Reasons
German-based Shop Apotheke’s CEO, Stefan Feltens, is about to step down from his position for personal reasons after four years in the role. Feltens will not be available for another term at the Annual General Meeting on April 26th, but will remain with the group until the end of May. The supervisory board is already searching for his successor from outside the company. Under Feltens' tenure, the number of Shop Apotheke's customers tripled to 9.3Μ and sales increased from €500Μ to €1.2Β.
Read More: Handelsblatt [article in German]. Google Translate in English here.
Manufacturers & Retailers Hiring Now:
Discover actively recruiting positions in the ePharmacy Industry below:
Digital Data & Performance Specialist, Bayer [🇭🇺]
More info: LinkedIn
Digital Product Owner PLM, Sanofi [🇪🇸]
More info: LinkedIn
Digital Transformation Lead, Pfizer [🇮🇪]
More info: LinkedIn
eCommerce Senior Associate, Elanco [🇪🇸]
More info: LinkedIn
Lead Innovation & Omnichannel Engagement, Novartis [🇨🇭]
More info: LinkedIn
Quiz: Are you an ePharmacy Wizard?
Every week a new trivia question will be asked to you regarding general facts related to the Pharmaceutical sector!
Which pharmaceutical company had the highest sales in 2022?
Sanofi
Haleon
Pfizer
Johnson & Johnson
Scroll down to the end of this email to reveal the answer.
Thank you for being with us for this week! In case you found ePharmacy News interesting please do not hesitate to share it.
🕵️ Send a confidential scoop to ePharmacy News: news@epharmacynews.com
Our weekly email can be delivered directly into your LinkedIn feed: link for LinkedIn ePharmacy News
The answer to this week’s quiz is: Pfizer. Pfizer (US$79.6bn +90%), takes the top spot in 2022, rising from sixth in 2021. Pfizer is a company that specializes in the development of drugs and vaccines for a variety of medical conditions, including cancer, cardiology, neurology, and immunology.